Skip to main content
Caplight Logo









Spot On Sciences

Spot On Sciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://spotonsciences.com

Last Round

M&A

Jul 1, 2018

Total Funding Raised

$335,000

Company Overview

Spot On Sciences is a medical device company that develops and manufactures innovative products for the collection, storage, and transport of biological fluid samples.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

dried blood spotDBSmicrosamplingremote blood collectionat-home blood testbiospecimen collectioncapillary blooddecentralized clinical trialsDCTmedical device manufacturersample stabilizationfinger-stick samplingambient temperature transportserum separationclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spot On Sciences Comparables

Compare Spot On Sciences with similar companies based on industry and business-model similarity.

Spot On Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DBS System SA
90%
Capitainer AB
83%
RedDrop Dx, Inc.
83%

Spot On Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AJul 1, 2018
GrantNov 10, 2014

Spot On Sciences Investors

Notable investors and investment history

Spot On Sciences investors
InvestorRounds
NIH RADxGrant
Kauffman FoundationGrant
Defense Advanced Research Projects AgencyGrant
Tribeca CompaniesM&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 26, 2026

    Monthly visitors increased 64% MoM.

  • Nov 7, 2025

    Monthly visitors grew 288% MoM.

Spot On Sciences Filings

Explore SEC and related filing metadata, where available.

Spot On Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spot On Sciences's valuation, stock price, and market status.

Is Spot On Sciences a public or private company?

Spot On Sciences is a private company.

What is the current stock price of Spot On Sciences?

Spot On Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is Spot On Sciences worth (valuation)?

Valuation information for Spot On Sciences is not publicly available.

Can I buy Spot On Sciences stock?

Spot On Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spot On Sciences's last funding round?

Spot On Sciences's most recent funding round was M&A on July 1, 2018.

Who are the main investors in Spot On Sciences?

Key investors in Spot On Sciences include NIH RADx, Kauffman Foundation, Defense Advanced Research Projects Agency, Tribeca Companies.

Will Spot On Sciences IPO soon?

No public IPO plans have been announced for Spot On Sciences.

How can I track Spot On Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spot On Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range5
Year Founded2010
Last FundingJul 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?